Voyager Therapeutics

Voyager Therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system. Its lead program is in Parkinson’s Disease and is entering Phase II trials. The goal of the trial is to use gene therapy to reduce the amount of levodopa that patients are required to take to maintain mobility which will reduce several negative side effects.